Objective-To determine the role of a cytokine-like protein DKK3 (dikkopf-3) in directly transdifferentiating fibroblasts into endothelial cells (ECs) and the underlying mechanisms. Approach and Results-DKK3 overexpression in human fibroblasts under defined conditions for 4 days led to a notable change in cell morphology and progenitor gene expression. It was revealed that these cells went through mesenchymalto-epithelial transition and subsequently expressed KDR (kinase insert domain receptor) at high levels. Further culture in EC defined media led to differentiation of these progenitors into functional ECs capable of angiogenesis both in vitro and in vivo, which was regulated by the VEGF (vascular endothelial growth factor)/miR (microRNA)-125a-5p/Stat3 (signal transducer and activator of transcription factor 3) axis. More importantly, fibroblast-derived ECs showed the ability to form a patent endothelium-like monolayer in tissue-engineered vascular grafts ex vivo. Conclusions-These data demonstrate that DKK3 is capable of directly differentiating human fibroblasts to functional ECs under defined media and provides a novel potential strategy for endothelial regeneration.
, a secreted glycoprotein, is a member of the dickkopf family of Wnt inhibitors. 1 It has been shown that DKK3 is involved in the differentiation of partially induced pluripotent 2 and embryonic stem cells 3 to smooth muscle cells (SMCs). 4 DKK3 was also identified to stimulate differentiation of Sca1 + (stem cell antigen 1) vascular progenitor cells and modify the phenotype of atherosclerotic plaque. 5 Recently, we have shown that DKK3 has a protective role in the pathogenesis of atherosclerosis via regulation of endothelial regeneration. 6 An attempt to clarify the mechanism involved in the regulation of angiogenesis by DKK3 indicates a correlation between this protein and VEGF (vascular endothelial growth factor). 6, 7 Meanwhile, the high expression of DKK3 in tumor vascularization suggests a function for DKK3 as an endothelial cell (EC) differentiation factor. 8 Taking these findings under consideration, it is postulated that DKK3 is a proangiogenic protein in both neovascularization and endothelial regeneration of large vessels.
ECs are key components of the vessel wall with immense potential in regenerative medicine and particularly cellular therapeutic strategies aiming to enhance tissueengineered constructs or rejuvenate ischemic tissues via neovascularization. Although several approaches have succeeded in generating functional ECs from various sources, such as embryonic stem cells, [9] [10] [11] induced pluripotent stem cells, [12] [13] [14] progenitor cells, 15, 16 or directly from terminally differentiated cell lines via combination of factors, 2,17 the complexity of the protocols, the low efficiencies, as well as the danger of contamination because of long term cultures and cultures containing feeder layers constitute obstacles in massively and safely generating ECs for clinical applications.
In this study, we presented a fast and straightforward protocol of generating functional ECs from human fibroblasts by overexpressing DKK3, under defined culture conditions. In addition, we explored possible mechanisms and revealed the involvement of mesenchymal-to-epithelial transition (MET) and the microRNA (miR)-125a-5p/Stat3 (signal transducer and activator of transcription factor 3) axis in regulating fibroblast transdifferentiation into ECs.
EC Differentiation
After 4 days of adenoviral transduction, null and human DKK3 overexpressing cells were changed to complete EGM-2 (EGM Endothelial Growth Medium [CC-3024] and EGM BulletKit [CC-3124]) supplemented with 10 ng/mL VEGF (Catalog No. 100-20B; Perpoteh).
In Vitro Tube Formation Assay
Chambers of an 8 well chamber slide were coated with 50 μL of Matrigel (Corning, catalog No. 356234) at 37 o C for 30 minutes to 1 hour. Control or induced EC (iECs; 10 4 ) were then seeded on top of the substrate and maintained in complete EGM-2-VEGF for 6 to 8 hours. Rearrangement of the cells and formation of capillary-like structures were then observed, and images were captured with an Axioplan 2 imaging microscope.
In Vivo Angiogenesis Assay
Control cells or iECs were mixed with 50 µL of Matrigel and injected subcutaneously into the back or flank of NOD.CB17-Prkdcscid/ NcrCrl mice (purchased from The Jackson Laboratory). Six injections were conducted for each group. Ten days later, the mice were euthanized, and the plugs were harvested, frozen in liquid nitrogen, and then cryosectioned. Samples were then fixed with 4% paraformaldehyde in PBS at 4°C overnight after which hematoxylin-eosin staining was applied. Images were assessed with the Axioplan 2 imaging microscope, captured with an AxioCam camera and processed with Photoshop software (Adobe) if required.
Dual Seeding Vascular Graft Using Ex Vivo Bioreactor System
The thoracic aorta was excised from the mouse (male C57Bl/6 mice were purchased from Charles River, Margate, Kent, United Kingdom) and immediately flushed with saline solution containing 100 U heparin to prevent the formation of blood clots. Periaortic connective tissue was gently removed with forceps. The vessel was harvested, and cryosection was prepared for further analysis.
shRNA Lentiviral Particle Transduction
Lentiviral particles were generated using shRNA (short hairpin RNA) E-Cadherin (CDH1 MISSION shRNA, SHCLNG_NM_004360; Sigma Aldrich) according to the protocol previously described. 2 Briefly, the shRNA nontargeting vector was used as negative control. HEK (human embryonic kidney) 293T cells were transfected with the lentiviral vector and the packaging plasmids, pCMV-dR8.2 (plasmid cytomegalovirus), and pCMV-VSV-G (G glycoprotein of vesicular stomatitis virus; both from Addgene) using FuGENE HD (Promega). The supernatant containing the lentiviral particles was collected and filtered 48 hours after transfection. For lentiviral transduction, cells were seeded overnight, and the following day, the cells were incubated with shRNA or nontargeting control in complete medium supplemented with 10 µg/mL of Polybrene for 16 hours. Subsequently, fresh medium was added to the cells, and the plates were harvested at the stated time points after transduction.
Statistical Analysis
The data were analyzed using Graph Pad Prism Software. Data were analyzed by 2-tailed Student t test or ANOVA followed by multiple comparisons with Bonferroni method when the data are passed for the normality and equal variance tests. Data were presented as the mean and SEM. A value of P<0.05 was considered significant.
Results

DKK3 Induces a Vascular Progenitor State in Fibroblasts Through MET
Human embryonic lung fibroblasts were infected with a null or DKK3 adenovirus and maintained in α-MEM (minimum essential medium) containing 10% Knockout Serum Replacement. DKK3 expression reached a higher level 2 day after infection and returned to baseline 7 days ( Figure IA and IB in the online-only Data Supplement). After maintaining the cells in these conditions, it was revealed that 4 days of DKK3 overexpression were sufficient to dramatically alter the cell morphology from an elongated and fiber-like phenotype to a smaller, rounder, and occasionally more spindle-like shape ( Figure 1A) . To elucidate the change in morphology, the expression levels of SMC and EC markers were initially investigated. It was found that most of the important SMC markers were significantly downregulated, whereas the EC markers were not significantly changed ( Figure IC and ID in the online-only Data Supplement).
To clarify the direction of the transformation, gene expression of the germ layers ectoderm and mesoderm was further investigated. Quantitative polymerase chain reaction analysis revealed that the change in the morphology of the cells was not a reflection of a transformation of the cells to any of the aforementioned layer ( Figure IE and IF in the online-only Data Supplement). Furthermore, an investigation of more specific cell lineages, such as cardiomyocytes and pericytes, showed that the cells did not adopt a specific cardiovascular phenotype ( Figure IG and II in the online-only Data Supplement).
To further characterize the newly generated cells and identify possible multipotent or progenitor characteristics, quantitative polymerase chain reaction and fluorescence-activated cell sorter (FACS) analysis were performed for both mesenchymal The participation of MET in modulating cellular identity has been shown in several studies. [18] [19] [20] Notably, quantitative polymerase chain reaction analysis showed that the expression of the epithelial marker E-cadherin was induced ( Figure 1E ) in parallel with the suppression of the mesenchymal markers FSP-1 (fibroblast-specific protein 1), Vimentin, Slug, and Fibronectin after 4 days of DKK3 overexpression ( Figure 1F and 1G). These results suggested that the generation of a vascular progenitor state occurs in parallel with a MET especially the suppression of mesenchymal signature genes. Silencing of E-Cadherin during reprogramming reduced expression of vascular progenitor markers, such as CD14 compared with Ad-DKK3 (adenovirus-DKK3) group, whereas the expression of mesenchymal gene marker FSP-1 was induced. (Figure 1H ). In vivo matrigel assay confirmed upregulation of E-Cadherin expression and downregulation of vimentin induction in Ad-DKK3 overexpressed cells ( Figure 1I ). Collectively, our results suggested that MET is indispensable during the transformation of fibroblasts to progenitor cells.
DKK3 Mediates Cell Differentiation into iECs via Activation of KDR Under Defined Condition
The significant induction of KDR during DKK3-induced vascular progenitor state suggested that DKK3 could regulate KDR expression through gene transcription. Luciferase assays indicated that the promoter region of KDR was activated upon DKK3 overexpression in different time points (Figure 2A and 2B). Immunofluorescence staining showed that KDR accumulated within cells with DKK3 overexpression (Figure 2C) . Results also showed that the transcription repressor TFII-1 that has been associated with KDR promoter activation was downregulated after DKK3 overexpression ( Figure IIIA and IIIB in the online-only Data Supplement).
The expression of a range of progenitor markers was an indication that the cells had entered a stage of plasticity that made them amenable to differentiation towards a specific cell type on the right stimulus. We, therefore, changed the culture medium to complete endothelial EGM-2 supplemented with VEGF for an additional 6 days. Initially, a dramatic change in cell shape was observed, where cells adopted a typical cobblestone morphology, characteristic of human ECs in culture ( Figure 2D ). After this observation, the expression of specific EC markers such as CD31 and CD144 were investigated at both the mRNA ( Figure 2E ) and protein levels ( Figure IVA through IVD in the online-only Data Supplement) and confirmed by immunofluorescent staining (Figure 2F ), which is comparable to those expressed in human umbilical cord ECs ( Figure 2G) . Furthermore, the expression of angiogenic markers of ECs, such as ANGPT1 (angiopoietin 1), ANGPT2 (angiopoietin 2), and Tie2, were investigated. It was found that the expression of these markers was significantly upregulated in parallel with important endothelial markers, such as KDR at the mRNA and protein levels ( Figure IVE and IVF in the online-only Data Supplement).
Finally, to confirm the angiogenic potential of these endothelial-like cells, a human angiogenic proteome profiler kit was utilized to detect 55 human angiogenesis-related proteins. Analysis of the microdot plots by densitometry showed that a greater number of proteins related to angiogenesis were upregulated in the endothelial-like differentiated cells as opposed to the control cells ( Figure V and Table II in the online-only Data Supplement). Although a general trend of upregulation was observed throughout the entire array, proteins, such as angiogenin, amphiregulin, EGF (epidermal growth factor), EG-VEGF (epidermal growth-VEGF), endothelin-1 IL-8 (interleukin-8), and TIMP-4 (tissue inhibitors of metalloproteinase 4) presented with the most prominent upregulations as shown in the boxed areas of the microdot plot. We, therefore, concluded that the cells had successfully differentiated to endothelial-like cells and henceforth called them iECs ( Figure 4E and 4F) , which was comparable with human umbilical cord ECs ( Figure 4G ).
miR-125a-5p/Stat3 Axis Is Implicated in Endothelial Differentiation
Several studies have demonstrated that miR-125a-5p regulates angiogenesis by directly binding to the 3'-untranslated region of Stat3 in ECs. 21, 22 We, therefore, postulated that the miR-125a-5p/Stat3 signaling pathway may be involved in the DKK3-induced iEC differentiation under defined condition. Congruently, our data revealed a consistent downregulation of miR-125a-5p as well as its precursor transcript expression ( Figure To further investigate the involvement of miR-125a-5p in EC differentiation, we performed loss-of-function and gainof-function experiments. Fibroblasts were overexpressed with DKK3 for 4 days and then differentiated toward ECs for an additional 6 days. At the third day of differentiation, cells were transfected with either miR-125a-5p mimics or inhibitor and were harvested 48 to 72 hours later. Overexpression of miR-125a-5p mimics reduced the expression of EC markers, such as CD144 and CD31, at both mRNA levels and protein level, whereas transfection with a miR-125a-5p inhibitor enhanced the expression of the aforementioned markers, respectively ( Figure 3A through 3C, Figure VID and VIE in the online-only Data Supplement). Importantly, cells revealed a decreased capacity to form vascular tubes in the presence of miR-125a-5p mimics. In contrary, iEC with miR-125a-5p inhibitor displayed an increased capacity to form vascular tubes in vitro (Figure 3D through 3F) .
Further experiments demonstrated that miR-125a-5p mimics suppressed the expression of Stat3, whereas miR125a-5p inhibitor-induced its expression ( Figure 3G through 3I). Additionally, luciferase assays revealed that the 3'untranslated region of Stat3 is a direct target of miR-125a-5p ( Figure 3J and 3K) . Interestingly, silencing of Stat3, either by siRNA (small interfering RNA) or a pharmacological inhibitor, led to a robust reduction of EC specific markers, as well as the in vitro tube formation during the DKK3-induced EC differentiation ( Figure 3L and 3M, Figure VIIA through VIIC in the online-only Data Supplement). We also found that Stat3 silencing led to a decrease of the gene promoter activity of CD144 and KDR ( Figure VIID and VIIE in the online-only Data Supplement). Furthermore, on siRNA-mediated knockdown of the Stat3, the regulatory effect of miR-125a-5p inhibition was ablated ( Figure 3N ). Collectively, these data confirm that miR125a-5p can modulate phenotypic switching and cell fate MicroRNA (miR)-125a-5p/Stat3 (signal transducer and activator of transcription factor 3) axis is implicated in DKK3 (dikkopf-3) transformed induced endothelial cell (iEC) differentiation. After 4 d of reprogramming, DKK3 transformed vascular progenitor cells were forced to differentiation toward EC for another 6 d, and then efficiently transfected with either miR-125a-5p mimics and inhibitor at day 3, cells were harvested on day 6. A, miR-125a-5p mimics decreased the EC specific marker expression and miR-125a-5p inhibitor (B) increased those EC marker expression, both in mRNA and protein level (C). On the day 6, the cells have been subjected to Matrigel plugs assay in vitro, miR-125a-5p reduced the tube formation comparison to the control, where more defined vascular structures were observed in miR-125a-5p inhibition (D and quantification in E, F scale bar=50 um). Meanwhile, miR-125a-5p overexpression suppressed the expression of Stat3 in mRNA level (G and H), the result of Western blot is shown in I. J, and K, DKK3 transformed ECs were cotransfected with miR-125a-5p mimics, inhibitor, relative control, and Stat3 untranslated region (3'UTR) report plasmid, luciferase assay demonstrating the 3 'UTR of Stat3 is a direct target gene of miR-125a-5p. L and M, Stat3 inhibition recapitulates the effects of miR-125a-5p overexpression on EC specific gene expression. N, the effect of the miR-125a-5p inhibitor in EC markers was ablated after Stat3 suppression. All graphic data are means±SEM from 3 independent experiments with duplicate samples. *Significant difference from the control, P<0.05. FLT1 indicates Fms-like tyrosine kinase 1; KDR, kinase insert domain receptor; inhib ctl, inhibitor control, mim ctl: mimics control, miR-125 inhib: miR-125a-5p inhibitor; miR-125 mim: miR-125a-5p mimics; mut, mutant; sineg, siRNA negative control; siStat3, stat3 siRNA; and VEGFA, vascular endothelial growth factor A. 
iECs Exhibit Endothelial Functions
After confirming the successful differentiation from fibroblasts to iECs, assessing the functionality of iECs was of vital importance. Initially, cells were seeded on a matrigel substrate to determine their angiogenic potential in vitro. Indeed, iECs formed cell networks after 6 to 8 hour of seeding, whereas the control cells never organized into such structures ( Figures 4A and 4B) . Furthermore, as shown in Figure 4C and 4D, iECs were capable of uptaking ac-LDL (low-density lipoprotein) which is the typical function of ECs. Finally, null-ECs or iECs were labeled with Qtracker (red) and subcutaneously injected into mice in the form of a matrigel plaque assay. It was revealed that iECs exhibited the ability to form microvascular tubular structures in vivo in 10 days as demonstrated by hematoxylin-eosin staining A, iECs were seeded on matrigel coated 6 well chamber slides and maintained in endothelial growth medium (EGM)-2-VEGF (vascular endothelial growth factor) medium for 6 to 8 h. Images captured with phase contrast microscopy revealed the formation of endothelial cell networks in iECs. B, Quantification of network structures formed by control and iECs on a matrigel substrate. C and D, Cells were incubated with an Alexa Fluor 594 Conjugated LDL (low-density lipoprotein) antibody and images were captured using fluorescent microscopy revealing an increased LDL uptake from iECs. E, Hematoxylin-eosin staining of sections obtained from the areas of injection after 10 d revealed the generation of microvascular tubes in the areas of iEC injection. F, Immunofluorescent staining for human CD144 (green) of frozen sections obtained from the same areas demonstrates that the labeled cells (red) forming the microvascular tubes are also positive for the human endothelial marker CD144. G, Decellularized mouse aorta graft double seeded with DKK3 (dikkopf-3)-transformed-ECs and smooth muscle cells showed vessel-like structures (red: CD31, green: α-SMA) after being maintained in ex vivo bioreactor setting for 5 d and was confirmed by human-specific CD31, CD144 immunostaining (H; mean±SEM, n= ≥5; *P<0.05). ac-LDL indicates acetylated low-density lipoprotein; Ad-DKK3, adenovirus-DKK3; and SMA, smooth muscle actin.
( Figure 4E ) and immunofluorescent staining for CD144 (green; Figure 4F ).
An ex vivo circulation bioreactor system developed in our lab has been used to seed cells to a decellularized mouse aortic graft to construct native vessel-comparable vascular grafts. 3 After seeding iEC into the decellularized graft and culturing the graft in the bioreactor circulation system for 5 days, the graft was harvested, sectioned, and stained for the endothelial marker CD31 and CD144 with immunofluorescence. The reconstructed vascular graft displayed a vascular-like structure with the most inner endothelium-like layer formed by DKK3 transformed iECs that were surrounded by multiple SMC layers ( Figure 4G and 4H) . Interestingly, the ability of angiogenesis in Matrigel plug was significantly influenced by treatment of the cells with miR-15-mimics ( Figure VIII in the online-only Data Supplement). Cell transfection with miR-125a-5p mimics resulted in decreased Stat3 expression correlated with decreased angiogenesis in vivo. Hence, we concluded that the iECs generated by fibroblasts via DKK3 adenoviral induction under defined culture conditions were functional ECs.
Discussion
It is of great significance to obtain human ECs of high quality to enhance angiogenesis in ischemic tissues and endothelial repair in large vessels and to generate functional vascular conduits. Although it has previously been shown that functional ECs can be derived from fibroblasts using reprogramming methods 2 of the correct combination of transcription factors, as well as the appropriate culture conditions, 17, 23 the simplicity of our protocol introduces for the first time a fast, 1 factor, straightforward transdifferentiation method to obtain functional ECs from human fibroblasts in the span of 10 days with no elaborate genetic manipulations. Although DKK3 has previously been associated with SMCs differentiation, 3 this study is further evidence to the notion that returning to an unstable, multipotent state is possible via different routes so long as the right circumstances have been generated for the cell to react to the appropriate stimulus.
Interestingly, we found that during the 4 days of reprogramming, fibroblasts gradually lost their morphology, as well as their mesenchymal gene marker expression, and simultaneously increased the expression of the cell-to-cell adhesion marker, E-cadherin, which is a crucial indicator of MET. 19 MET is a key process involved in the manipulation of cell fate plasticity. 20, 24 Furthermore, knockdown of E-cadherin disrupted vascular progenitor marker induction. Successful interactions between neighboring cells mediated by E-cadherin may be a requisite event for the further establishment of vascular progenitor and endothelial junction proteins. There is no change in gene expression of pluripotency marker Oct-4 (octamer-binding transcription factor 4), Sox2 (sex-determining region Y-box 2), Klf4 (Kruppel-like factor 4), and c-myc (c-myelocytomatosis viral oncogene) in the infected cells (data not shown). In addition, high KDR expression was detected in our cell model. KDR, the receptor for VEGF, is the earliest marker of the endothelial lineage to be expressed during development. 25 Activation of KDR in our system suggests that these cells may be responsive to VEGF stimulation and thus capable of differentiation to ECs. We, therefore, changed the medium to include recombinant VEGF. Our results indicated that DKK3 can successfully differentiate fibroblasts to ECs under defined condition. Importantly, these iECs displayed good attachment, typical endothelial structure, and functional properties, providing an excellent source of cells for the use in regenerative therapy.
To shed light onto the mechanism by which DKK3 induces iECs differentiation, we focus on the miR-125a-5p/ Stat3 axis pathway, Stat3 is well-characterized as aspect of mediated angiogenic regulation and required for endothelial differentiation in stem cells, 26 miR-125a-5p can regulate angiogenesis 22 and has been verified as a tumor suppressor by targeting Stat3. In this study, we provide compelling evidence that Stat3 is the directly target of miR-125a-5p and mediated the DKK3 transformed iEC differentiation process by the following: (1) decrease the gene expression of endothelial specific markers, such as CD144, CD31 by Stat3 suppression and miR-125a-5p overexpression; (2) reduction of Stat3 expression and its reporter activity by miR-125a-5p mimics; (3) the effect of miR-125a-5p on iEC differentiation can be abolished after Stat3 depletion. Above evidence demonstrated the novel mechanistic roles involved the miR-125a-5p/Stat3 signaling pathway during the fibroblast transdifferentiation to endothelial lineage ( Figure IX in the online-only Data Supplement).
Therefore, we think that DKK3 overexpression under the defined culture conditions can induce a progenitor-like state to the cells that transforms them into a cell type amenable to appropriately respond to potent endothelial signals, bringing 1-factor transdifferentiation for personalized therapy within our grasp. Moreover, our method provides the ability to differentiate into ECs through defined media by skipping pluripotency then prevents the risk of tumor formation. This study also has implications since generation of a large population of functional ECs can fundamentally change personalized vascular therapy.
